Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
EditorialEditorial

The breakthrough in primary human hepatocytes in vitro expansion

Mei Feng, Ruirui Kong and Yisheng Pan
Cancer Biology & Medicine February 2019, 16 (1) 1-3; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0030
Mei Feng
1Translational Cancer Research Center
2Department of General Surgery, Peking University First Hospital, Beijing 100034, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruirui Kong
1Translational Cancer Research Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected] [email protected]
Yisheng Pan
1Translational Cancer Research Center
2Department of General Surgery, Peking University First Hospital, Beijing 100034, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected] [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    1

    PHHs in vitro expansion. Schematic diagram illustrates the expansion of PHHs from diversified individuals to a large quantity, when cultured in HM established by Hui et al,10 with the addition of Wnt3a and removal of Rspo1, Noggin and forskolin. The ProliHHs maintained a bi-phenotypic status between primary hepatocytes and liver progenitor cells can mature after inducing re-differentiation by 3D culture and repopulate when transplanted into the liver of immuno-deficient Fah knockout mice indicated. Undoubtedly, this will provide a useful model system for disease modeling such as hepatotropic virus infection, as well as for new drug safety assessment and toxicity testing in vitro and paved the way for hepatocyte transplantation therapy to be used on liver disease patients in the future.

PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 16 (1)
Cancer Biology & Medicine
Vol. 16, Issue 1
1 Feb 2019
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The breakthrough in primary human hepatocytes in vitro expansion
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
The breakthrough in primary human hepatocytes in vitro expansion
Mei Feng, Ruirui Kong, Yisheng Pan
Cancer Biology & Medicine Feb 2019, 16 (1) 1-3; DOI: 10.20892/j.issn.2095-3941.2019.0030

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The breakthrough in primary human hepatocytes in vitro expansion
Mei Feng, Ruirui Kong, Yisheng Pan
Cancer Biology & Medicine Feb 2019, 16 (1) 1-3; DOI: 10.20892/j.issn.2095-3941.2019.0030
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Introduction
    • Perspective
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • A breakthrough in liver regeneration for treatment of liver cancer
  • Google Scholar

More in this TOC Section

  • Advances in the treatment of metastatic prostate cancer in China
  • Chinese Society of Clinical Oncology Non-small Cell Lung Cancer (CSCO NSCLC) guidelines in 2024: key update on the management of early and locally advanced NSCLC
  • Updates to the 2024 CSCO advanced non-small cell lung cancer guidelines
Show more Editorial

Similar Articles

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire